Amgen
AMGN
#99
Rank
โ‚ฌ152.57 B
Marketcap
283,34ย โ‚ฌ
Share price
-3.02%
Change (1 day)
12.09%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

EPS for Amgen (AMGN)

EPS in 2025 (TTM): 11,45ย โ‚ฌ

According to Amgen's latest financial reports the company's current EPS (TTM) is 11,19ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 6,54ย โ‚ฌ a decrease over its 2023 EPS that were of 10,79ย โ‚ฌ.

EPS history for Amgen from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)11,45ย โ‚ฌ74.99%
20246,54ย โ‚ฌ-39.33%
202310,79ย โ‚ฌ3.12%
202210,46ย โ‚ฌ17.57%
20218,90ย โ‚ฌ-16.38%
202010,64ย โ‚ฌ-4.32%
201911,12ย โ‚ฌ2.05%
201810,90ย โ‚ฌ382.51%
20172,26ย โ‚ฌ-74.52%
20168,86ย โ‚ฌ12.66%
20157,87ย โ‚ฌ34.9%
20145,83ย โ‚ฌ0.74%
20135,79ย โ‚ฌ20.36%
20124,81ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,48ย โ‚ฌ-86.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,55ย โ‚ฌ-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,09ย โ‚ฌ-72.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
5,60ย โ‚ฌ-49.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
9,44ย โ‚ฌ-15.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,16ย โ‚ฌ-89.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-19.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
3,84ย โ‚ฌ-65.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
17,62ย โ‚ฌ 57.47%๐Ÿ‡บ๐Ÿ‡ธ USA